S&P 500 Futures
(0.77%) 5 121.50 points
Dow Jones Futures
(0.15%) 38 347 points
Nasdaq Futures
(1.08%) 17 758 points
Oil
(0.32%) $83.84
Gas
(-3.54%) $1.580
Gold
(0.64%) $2 357.50
Silver
(1.34%) $27.72
Platinum
(1.08%) $930.40
USD/EUR
(-0.13%) $0.930
USD/NOK
(0.01%) $10.95
USD/GBP
(-0.12%) $0.798
USD/RUB
(0.13%) $92.29

Realtime updates for 2cureX AB (publ) [2CUREX.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated26 Apr 2024 @ 03:29

-19.15% SEK 0.380

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 03:29):

2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment...

Stats
Today's Volume 50.00
Average Volume 78 204.00
Market Cap 6.69M
EPS SEK-0.577 ( 2023-11-22 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -0.200
ATR14 SEK0 (0.00%)

2cureX AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

2cureX AB (publ) Financials

Annual 2023
Revenue: SEK155 000
Gross Profit: SEK-37.49M (-24 185.16 %)
EPS: SEK-1.750
FY 2023
Revenue: SEK155 000
Gross Profit: SEK-37.49M (-24 185.16 %)
EPS: SEK-1.750
FY 2022
Revenue: SEK90 000.00
Gross Profit: SEK-35.41M (-39 346.67 %)
EPS: SEK-1.560
FY 2021
Revenue: SEK0.00
Gross Profit: SEK0.00 (0.00 %)
EPS: SEK-1.150

Financial Reports:

No articles found.

2cureX AB (publ)

2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. The company is also conducting various clinical programs for IndiTreat for breast colorectal, ovarian, and pancreatic cancers. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators